These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 1950741)
21. No added benefit from nebulized amiloride in patients with cystic fibrosis. Graham A; Hasani A; Alton EW; Martin GP; Marriott C; Hodson ME; Clarke SW; Geddes DM Eur Respir J; 1993 Oct; 6(9):1243-8. PubMed ID: 8287938 [TBL] [Abstract][Full Text] [Related]
22. Effect of inhaled amiloride on water-induced bronchoconstriction in asthmatic children. Mochizuki H; Shimizu T; Shigeta M; Tokuyama K; Morikawa A; Kuroume T Am J Respir Crit Care Med; 1994 Aug; 150(2):555-7. PubMed ID: 8049846 [TBL] [Abstract][Full Text] [Related]
23. Controlled trial of intermittent aerosol therapy with sodium 2-mercaptoethane sulphonate in cystic fibrosis. Weller PH; Ingram D; Preece MA; Matthew DJ Thorax; 1980 Jan; 35(1):42-6. PubMed ID: 6767295 [TBL] [Abstract][Full Text] [Related]
24. Effect of rhDNase on airflow obstruction and mucociliary clearance in cystic fibrosis. Laube BL; Auci RM; Shields DE; Christiansen DH; Lucas MK; Fuchs HJ; Rosenstein BJ Am J Respir Crit Care Med; 1996 Feb; 153(2):752-60. PubMed ID: 8564129 [TBL] [Abstract][Full Text] [Related]
25. Airway deposition and clearance and systemic pharmacokinetics of amiloride following aerosolization with an ultrasonic nebulizer to normal airways. Noone PG; Regnis JA; Liu X; Brouwer KL; Robinson M; Edwards L; Knowles MR Chest; 1997 Nov; 112(5):1283-90. PubMed ID: 9367469 [TBL] [Abstract][Full Text] [Related]
26. Inhaled mannitol improves the hydration and surface properties of sputum in patients with cystic fibrosis. Daviskas E; Anderson SD; Jaques A; Charlton B Chest; 2010 Apr; 137(4):861-8. PubMed ID: 19880909 [TBL] [Abstract][Full Text] [Related]
27. [Amiloride hydrochloride nebulized by oxygen in the treatment of mucoviscidosis]. Lenoir G; Willemot JM; Pradier J; Broissand C; Silly C; Briend R Rev Mal Respir; 1992; 9(6):613-6. PubMed ID: 1470753 [TBL] [Abstract][Full Text] [Related]
28. Effect of amiloride and saline on nasal mucociliary clearance and potential difference in cystic fibrosis and normal subjects. Middleton PG; Geddes DM; Alton EW Thorax; 1993 Aug; 48(8):812-6. PubMed ID: 8211871 [TBL] [Abstract][Full Text] [Related]
29. Efficacy and safety of short-term administration of aerosolised recombinant human DNase I in adults with stable stage cystic fibrosis. Ranasinha C; Assoufi B; Shak S; Christiansen D; Fuchs H; Empey D; Geddes D; Hodson M Lancet; 1993 Jul; 342(8865):199-202. PubMed ID: 8100928 [TBL] [Abstract][Full Text] [Related]
30. An alternative aerosol delivery system for amiloride. Everard ML; Devadason SG; Sunderland VB; Le Souef PN Thorax; 1995 May; 50(5):517-9. PubMed ID: 7597664 [TBL] [Abstract][Full Text] [Related]
31. Safety and efficacy of recombinant alpha(1)-antitrypsin therapy in cystic fibrosis. Martin SL; Downey D; Bilton D; Keogan MT; Edgar J; Elborn JS; Pediatr Pulmonol; 2006 Feb; 41(2):177-83. PubMed ID: 16372352 [TBL] [Abstract][Full Text] [Related]
32. Recombinant human DNase inhalation in normal subjects and patients with cystic fibrosis. A phase 1 study. Aitken ML; Burke W; McDonald G; Shak S; Montgomery AB; Smith A JAMA; 1992 Apr; 267(14):1947-51. PubMed ID: 1548827 [TBL] [Abstract][Full Text] [Related]
33. Small airway deposition of dornase alfa during exacerbations in cystic fibrosis; a randomized controlled clinical trial. Bakker EM; Volpi S; Salonini E; Müllinger B; Kroneberg P; Bakker M; Hop WC; Assael BM; Tiddens HA Pediatr Pulmonol; 2014 Feb; 49(2):154-61. PubMed ID: 23913868 [TBL] [Abstract][Full Text] [Related]
34. [Comparative study of the performance and ergonomics of nebulizers in cystic fibrosis]. Faurisson F; Dessanges JF; Grimfeld A; Beaulieu R; Kitzis MD; Peytavin G; Lefevre JP; Farinotti R; Sautegeau A Rev Mal Respir; 1996; 13(2):155-62. PubMed ID: 8711234 [TBL] [Abstract][Full Text] [Related]
35. Efficacy and safety of short-term administration of aerosolized recombinant human deoxyribonuclease in patients with cystic fibrosis. Ramsey BW; Astley SJ; Aitken ML; Burke W; Colin AA; Dorkin HL; Eisenberg JD; Gibson RL; Harwood IR; Schidlow DV Am Rev Respir Dis; 1993 Jul; 148(1):145-51. PubMed ID: 8317790 [TBL] [Abstract][Full Text] [Related]
36. Safety and pharmacokinetics of ciprofloxacin dry powder for inhalation in cystic fibrosis: a phase I, randomized, single-dose, dose-escalation study. Stass H; Delesen H; Nagelschmitz J; Staab D J Aerosol Med Pulm Drug Deliv; 2015 Apr; 28(2):106-15. PubMed ID: 25050456 [TBL] [Abstract][Full Text] [Related]
37. Effect of hypertonic saline, amiloride, and cough on mucociliary clearance in patients with cystic fibrosis. Robinson M; Regnis JA; Bailey DL; King M; Bautovich GJ; Bye PT Am J Respir Crit Care Med; 1996 May; 153(5):1503-9. PubMed ID: 8630593 [TBL] [Abstract][Full Text] [Related]
38. Dornase aerosol effect on sputum viscosity in cases of cystic fibrosis. Lieberman J JAMA; 1968 Jul; 205(5):312-3. PubMed ID: 5694947 [No Abstract] [Full Text] [Related]
39. Bolus inhalation of rhDNase with the AERx system in subjects with cystic fibrosis. Geller D; Thipphawong J; Otulana B; Caplan D; Ericson D; Milgram L; Okikawa J; Quan J; Bowman CM J Aerosol Med; 2003; 16(2):175-82. PubMed ID: 12823911 [TBL] [Abstract][Full Text] [Related]
40. Inhaled dry powder mannitol in children with cystic fibrosis: A randomised efficacy and safety trial. De Boeck K; Haarman E; Hull J; Lands LC; Moeller A; Munck A; Riethmüller J; Tiddens H; Volpi S; Leadbetter J; Charlton B; Malfroot A; J Cyst Fibros; 2017 May; 16(3):380-387. PubMed ID: 28258928 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]